INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2024) Q1 2025 |
(Sep 30 2024) Q4 2024 |
(Jun 30 2024) Q3 2024 |
(Mar 31 2024) Q2 2024 |
(Dec 31 2023) Q1 2024 |
Revenue From Contract With Customer Excluding Assessed Tax |
61.69 |
|
56.04 |
94.54 |
91.99 |
Total Revenue |
61.69 |
60.86 |
56.04 |
94.54 |
91.99 |
Other Cost of Operating Revenue |
21.03 |
5.03 |
4.72 |
21.18 |
20.42 |
Gross
Profit |
40.66 |
33.11 |
51.32 |
73.36 |
71.57 |
Selling, Administration, Marketing |
28.90 |
23.66 |
45.03 |
54.16 |
53.53 |
Depriciation & Amortization |
7.68 |
2.02 |
6.97 |
10.07 |
9.74 |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
18.00 |
-0.02 |
0.00 |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability |
- |
0.53 |
- |
-0.29 |
-0.24 |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Including Discontinued Operations Liability |
1.38 |
-0.67 |
- |
- |
- |
Total operating costs including COS |
58.99 |
71.29 |
56.71 |
85.12 |
83.46 |
Operating income/-loss
|
2.70 |
3.55 |
-0.67 |
9.42 |
8.53 |
Other Deductions / - Income |
Interest expense |
0.68 |
- |
7.91 |
7.75 |
6.71 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.68 |
21.36 |
7.91 |
7.75 |
6.71 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-1.83 |
-15.70 |
0.00 |
-2.26 |
0.11 |
Total costs & expenses |
57.85 |
-2.22 |
64.61 |
90.61 |
90.27 |
Income /-loss before income taxes |
3.85 |
-16.09 |
-8.58 |
3.93 |
1.72 |
Income taxes expenses/-benefit |
0.52 |
-11.70 |
5.27 |
0.58 |
0.18 |
Income after income taxes |
3.32 |
0.50 |
-13.85 |
3.35 |
1.54 |
Net income/-loss
of other equity |
-0.08 |
64.55 |
1.66 |
- |
- |
Income/-loss
from cont. Ops. |
3.25 |
60.17 |
-12.18 |
3.35 |
1.54 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
-0.14 |
111.58 |
3.89 |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
3.11 |
178.54 |
-8.30 |
3.35 |
1.54 |
Noncontrolling interests |
1.05 |
60.63 |
-0.75 |
1.47 |
0.44 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
-0.08 |
64.55 |
1.66 |
- |
- |
Income/-loss to shareholder |
2.06 |
117.91 |
-7.55 |
1.88 |
1.10 |
EBIT |
4.53 |
5.27 |
-0.67 |
11.68 |
8.43 |
EBITD |
4.53 |
5.27 |
-0.67 |
21.75 |
18.16 |
EBITDA |
4.81 |
5.55 |
-0.45 |
22.01 |
18.58 |